GeneTether Therapeutics, Inc. (TSE:GTTX)
CNQX:GTTX
Canadian Market
Holding TSE:GTTX?
Track your performance easily

GeneTether Therapeutics, Inc. (GTTX) Cash flow

3 Followers

GeneTether Therapeutics, Inc. Cash Flow

TSE:GTTX's free cash flow for Q2 2024 was $-209.31K. For the 2024 fiscal year, TSE:GTTX's free cash flow was decreased by $712.92K and operating cash flow was $-209.31K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -356.32K$ -464.86K$ -1.18M$ -740.26K$ -69.06K
Investing Cash Flow
-----
Financing Cash Flow
--$ 3.00M$ 874.71K$ 104.33K
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 5.01M$ 1.36M$ 1.80M$ 179.83K$ 45.39K
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
-----
Issuance Of Capital Stock
--$ 3.00M$ 874.71K$ 3.33K
Issuance Of Debt
----$ 101.00K
Repayment Of Debt
-----
Free Cash Flow
$ -356.32K$ -464.86K$ -1.18M$ -740.26K$ -69.06K
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

GeneTether Therapeutics, Inc. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis